Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production - PubMed (original) (raw)

. 1999 Mar 15;162(6):3559-65.

Affiliations

PMID: 10092814

Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production

M Yanagita et al. J Immunol. 1999.

Abstract

To investigate the antibacterial activity of mucosal Th1 and Th2 immune responses induced nasally and orally, mice were immunized with mucosal vaccine containing fimbrial protein of Porphyromonas gingivalis, a causative agent for a destructive chronic inflammation in the periodontium, and cholera toxin (CT) as mucosal adjuvant. Nasal vaccine containing low doses of fimbriae (10 micrograms) and CT (1 microgram) induced Ag-specific Th1/Th2-type response in CD4+ T cells in mucosal effector tissues, including nasal passage and submandibular glands, which accounted for the generation of Ag-specific IgA-producing cells. In contrast, oral immunization required higher amounts of fimbriae and CT for the induction of Ag-specific IgA responses. Fimbriae-specific IgA mAbs generated from submandibular glands of nasally immunized mice inhibited P. gingivalis attachment to and reduced subsequent inflammatory cytokine production from epithelial cells. These findings suggest that nasal vaccination is an effective immunization regimen for the induction of Ag-specific Th1 and Th2 cell-driven IgA immune responses that possess the ability to inhibit bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.

PubMed Disclaimer

Cited by

Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.
Nakagaki H, Sekine S, Terao Y, Toe M, Tanaka M, Ito HO, Kawabata S, Shizukuishi S, Fujihashi K, Kataoka K. Nakagaki H, et al. Infect Immun. 2010 Mar;78(3):1185-92. doi: 10.1128/IAI.01224-09. Epub 2009 Dec 14. Infect Immun. 2010. PMID: 20008529 Free PMC article.
DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
Han X, LaRosa KB, Kawai T, Taubman MA. Han X, et al. Vaccine. 2014 Jan 3;32(2):297-303. doi: 10.1016/j.vaccine.2013.09.004. Epub 2013 Sep 16. Vaccine. 2014. PMID: 24051159 Free PMC article.
Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients.
Zhao Y, Liu Y, Yi F, Zhang J, Xu Z, Liu Y, Tao Y. Zhao Y, et al. Int Immunopharmacol. 2021 Apr;93:107406. doi: 10.1016/j.intimp.2021.107406. Epub 2021 Jan 22. Int Immunopharmacol. 2021. PMID: 33601246 Free PMC article.
The local immune response during Echinococcus granulosus growth in a quantitative hepatic experimental model.
Li Z, Zhang C, Li L, Bi X, Li L, Yang S, Zhang N, Wang H, Yang N, Abulizi A, Aini A, Lin R, Vuitton DA, Wen H. Li Z, et al. Sci Rep. 2019 Dec 23;9(1):19612. doi: 10.1038/s41598-019-56098-3. Sci Rep. 2019. PMID: 31873157 Free PMC article.
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.
Medaglini D, Ciabattini A, Cuppone AM, Costa C, Ricci S, Costalonga M, Pozzi G. Medaglini D, et al. Infect Immun. 2006 May;74(5):2760-6. doi: 10.1128/IAI.74.5.2760-2766.2006. Infect Immun. 2006. PMID: 16622213 Free PMC article.

Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production - PubMed (original) (raw)